The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for ...

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

A bill that would allow prosecutors to bring prior offenses into domestic violence cases prompted concerns about fair trials.

OCTC students host Salem Witch Trials exhibit ...

Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing ...

Racial disparities in pediatric eye disease exist, and how here's how medical providers can improve participation in clinical ...

Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...

Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

Boy Kills World’ on Hulu, a Hyperviolent Comix-Meets-Video Games Revenge Flick Starring Bill Sarsgard 'The Penguin' Series ...

The NIH called the first phase of the initiative Researching COVID to Enhance Recovery (RECOVER). Its newest project will be ...